Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 26, 2024

SELL
$1.25 - $2.35 $312 - $587
-250 Reduced 71.43%
100 $0
Q1 2021

Apr 21, 2021

BUY
$5.68 - $7.87 $1,988 - $2,754
350 New
350 $2,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $298M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Prairie View Partners, LLC Portfolio

Follow Prairie View Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prairie View Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prairie View Partners, LLC with notifications on news.